Cargando…
Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial Cancer
BACKGROUND: Every year approximately 74,000 women die of endometrial cancer, mainly due to recurrent or metastatic disease. The presence of tumor infiltrating lymphocytes (TILs) as well as progesterone receptor (PR) positivity has been correlated with improved prognosis. This study describes two mec...
Autores principales: | van der Horst, Paul H., Wang, Yongyi, Vandenput, Ingrid, Kühne, Liesbeth C., Ewing, Patricia C., van IJcken, Wilfred F. J., van der Zee, Marten, Amant, Frederic, Burger, Curt W., Blok, Leen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266274/ https://www.ncbi.nlm.nih.gov/pubmed/22295114 http://dx.doi.org/10.1371/journal.pone.0030840 |
Ejemplares similares
-
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer
por: Wang, Yongyi, et al.
Publicado: (2010) -
Identification of Quiescent, Stem-Like Cells in the Distal Female Reproductive Tract
por: Wang, Yongyi, et al.
Publicado: (2012) -
Dietary Progesterone Contributes to Intratissue Levels of Progesterone in Male Mice
por: Colldén, Hannah, et al.
Publicado: (2023) -
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
por: Vandenput, I, et al.
Publicado: (2009) -
Modeling Endometrial Cancer: Past, Present, and Future
por: Van Nyen, Tom, et al.
Publicado: (2018)